Literature DB >> 8668155

Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter.

J Botz1, K Zerfass-Thome, D Spitkovsky, H Delius, B Vogt, M Eilers, A Hatzigeorgiou, P Jansen-Dürr.   

Abstract

Cyclin E controls progression through the G1 phase of the cell cycle in mammalian fibroblasts and potentially in many other cell types. Cyclin E is a rate-limiting activator of cdk2 kinase in late G1. The abundance of cyclin E is controlled by phase-specific fluctuations in the mRNA level; in mammalian fibroblasts, mRNA is not detected under conditions of serum starvation and is accumulated upon serum stimulation, with expression starting in mid-G1. Here, we report the cloning of the murine cyclin E promoter. We isolated a 3.8-kb genomic fragment that contains several transcriptional start sites and confers cell cycle regulation on a luciferase reporter gene. This fragment also supports transcriptional activation by adenovirus E1A, a known upstream regulator of cyclin E gene expression. An E2F binding site which is required for G1-specific activation of the cyclin E promoter in synchronized NIH 3T3 cells was identified in this fragment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668155      PMCID: PMC231334          DOI: 10.1128/MCB.16.7.3401

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Cyclin A is required in S phase in normal epithelial cells.

Authors:  F Zindy; E Lamas; X Chenivesse; J Sobczak; J Wang; D Fesquet; B Henglein; C Bréchot
Journal:  Biochem Biophys Res Commun       Date:  1992-02-14       Impact factor: 3.575

2.  An intron within the 16S ribosomal RNA gene of the archaeon Pyrobaculum aerophilum.

Authors:  S Burggraf; N Larsen; C R Woese; K O Stetter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

3.  Regulation of the cyclin E gene by transcription factor E2F1.

Authors:  K Ohtani; J DeGregori; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

4.  Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E.

Authors:  A Wimmel; F C Lucibello; A Sewing; S Adolph; R Müller
Journal:  Oncogene       Date:  1994-03       Impact factor: 9.867

5.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

Authors:  A Koff; A Giordano; D Desai; K Yamashita; J W Harper; S Elledge; T Nishimoto; D O Morgan; B R Franza; J M Roberts
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

6.  Association of human cyclin E with a periodic G1-S phase protein kinase.

Authors:  V Dulić; E Lees; S I Reed
Journal:  Science       Date:  1992-09-25       Impact factor: 47.728

7.  Interactions of the p107 and Rb proteins with E2F during the cell proliferation response.

Authors:  J K Schwarz; S H Devoto; E J Smith; S P Chellappan; L Jakoi; J R Nevins
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

8.  Cyclin A is required at two points in the human cell cycle.

Authors:  M Pagano; R Pepperkok; F Verde; W Ansorge; G Draetta
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

9.  HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes.

Authors:  E W Lam; J D Morris; R Davies; T Crook; R J Watson; K H Vousden
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

10.  G1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter.

Authors:  Q P Dou; S Zhao; A H Levin; J Wang; K Helin; A B Pardee
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.486

View more
  69 in total

1.  CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase.

Authors:  E Vigo; H Müller; E Prosperini; G Hateboer; P Cartwright; M C Moroni; K Helin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression.

Authors:  X Chen; R Prywes
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.

Authors:  E Santoni-Rugiu; J Falck; N Mailand; J Bartek; J Lukas
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

4.  E2F mediates developmental and cell cycle regulation of ORC1 in Drosophila.

Authors:  M Asano; R P Wharton
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

5.  Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.

Authors:  L Le Cam; J Polanowska; E Fabbrizio; M Olivier; A Philips; E Ng Eaton; M Classon; Y Geng; C Sardet
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

6.  Target gene specificity of E2F and pocket protein family members in living cells.

Authors:  J Wells; K E Boyd; C J Fry; S M Bartley; P J Farnham
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  NPAT expression is regulated by E2F and is essential for cell cycle progression.

Authors:  Guang Gao; Adrian P Bracken; Karina Burkard; Diego Pasini; Marie Classon; Claire Attwooll; Masashi Sagara; Takashi Imai; Kristian Helin; Jiyong Zhao
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins.

Authors:  J Hermanns; A Schulze; P Jansen-Db1urr; J A Kleinschmidt; R Schmidt; H zur Hausen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

9.  Mutations in Drosophila DP and E2F distinguish G1-S progression from an associated transcriptional program.

Authors:  I Royzman; A J Whittaker; T L Orr-Weaver
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

10.  Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor.

Authors:  Tatiana V Petrova; Taija Mäkinen; Tomi P Mäkelä; Janna Saarela; Ismo Virtanen; Robert E Ferrell; David N Finegold; Dontscho Kerjaschki; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.